ID   HEK293-MRP7
AC   CVCL_B3Q1
SY   HEK293/MRP7
DR   Wikidata; Q110432862
RX   PubMed=26579384;
RX   PubMed=34631561;
CC   Transfected with: HGNC; 52; ABCC10.
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
RX   PubMed=26579384; DOI=10.1016/j.apsb.2014.02.003;
RA   Anreddy N., Patel A., Sodani K., Kathawala R.J., Chen E.P.,
RA   Wurpel J.N.D., Chen Z.-S.;
RT   "PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated
RT   MDR.";
RL   Acta Pharm. Sin. B. 4:202-207(2014).
//
RX   PubMed=34631561; DOI=10.3389/fonc.2021.731260;
RA   Wang J.-Q., Wu Z.-X., Yang Y., Li J.-S., Yang D.-H., Fan Y.-F.,
RA   Chen Z.-S.;
RT   "Establishment and characterization of a novel multidrug resistant
RT   human ovarian cancer cell line with heterogenous MRP7
RT   overexpression.";
RL   Front. Oncol. 11:731260.1-731260.10(2021).
//